Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration.

Leelawat S, Leelawat K, Narong S, Matangkasombut O.

Cancer Invest. 2010 May;28(4):357-63. doi: 10.3109/07357900903405934.

PMID:
19916793
2.

Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.

Sugiyama H, Onuki K, Ishige K, Baba N, Ueda T, Matsuda S, Takeuchi K, Onodera M, Nakanuma Y, Yamato M, Yamamoto M, Hyodo I, Shoda J.

J Gastroenterol. 2011 Jun;46(6):779-89. doi: 10.1007/s00535-011-0380-3. Epub 2011 Feb 18.

PMID:
21331764
3.

Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.

Kim JH, Liu L, Lee SO, Kim YT, You KR, Kim DG.

Cancer Res. 2005 Jul 15;65(14):6312-20.

4.

Modulatory role of garlicin in migration and invasion of intrahepatic cholangiocarcinoma via PI3K/AKT pathway.

Xie K, Nian J, Zhu X, Geng X, Liu F.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14028-33. eCollection 2015 Nov 1.

5.

Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.

Jinawath A, Akiyama Y, Sripa B, Yuasa Y.

J Cancer Res Clin Oncol. 2007 Apr;133(4):271-8. Epub 2006 Nov 25.

PMID:
17294242
6.
7.

Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma.

Hong SM, Park CW, Cha HJ, Kwon JH, Yun YS, Lee NG, Kim DG, Nam HG, Choi KY.

Clin Exp Metastasis. 2013 Feb;30(2):177-87. doi: 10.1007/s10585-012-9526-9. Epub 2012 Aug 9.

PMID:
22875246
8.
9.

Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.

Jia W, Hegde VL, Singh NP, Sisco D, Grant S, Nagarkatti M, Nagarkatti PS.

Mol Cancer Res. 2006 Aug;4(8):549-62.

10.

Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells.

Ishimura N, Isomoto H, Bronk SF, Gores GJ.

Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G129-36. Epub 2005 Sep 15.

11.

Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.

Okabe H, Beppu T, Hayashi H, Ishiko T, Masuda T, Otao R, Horlad H, Jono H, Ueda M, Phd SS, Ando Y, Baba H.

Ann Surg Oncol. 2011 Apr;18(4):1175-84. doi: 10.1245/s10434-010-1391-7. Epub 2010 Nov 2.

PMID:
21042948
12.

Imatinib mesylate induces apoptosis in human cholangiocarcinoma cells.

Chiorean MV, Guicciardi ME, Yoon JH, Bronk SF, Kaufmanns SH, Gores GJ.

Liver Int. 2004 Dec;24(6):687-95.

PMID:
15566522
13.

Downregulation of ROS-FIG inhibits cell proliferation, colony‑formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells.

Deng G, Hu C, Zhu L, Huang F, Huang W, Xu H, Nie W.

Int J Mol Med. 2014 Sep;34(3):661-8. doi: 10.3892/ijmm.2014.1823. Epub 2014 Jun 27.

14.

Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway.

Techasen A, Loilome W, Namwat N, Takahashi E, Sugihara E, Puapairoj A, Miwa M, Saya H, Yongvanit P.

Cancer Sci. 2010 Mar;101(3):658-65. doi: 10.1111/j.1349-7006.2009.01427.x. Epub 2009 Nov 7.

15.

Expression and antitumor effects of TRAIL in human cholangiocarcinoma.

Tanaka S, Sugimachi K, Shirabe K, Shimada M, Wands JR.

Hepatology. 2000 Sep;32(3):523-7.

PMID:
10960444
16.

Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.

Xiong GP, Zhang JX, Gu SP, Wu YB, Liu JF.

Neoplasma. 2012;59(4):409-15. doi: 10.4149/neo_2012_053.

PMID:
22489696
17.

Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines.

Iwahashi S, Ishibashi H, Utsunomiya T, Morine Y, Ochir TL, Hanaoka J, Mori H, Ikemoto T, Imura S, Shimada M.

J Med Invest. 2011 Feb;58(1-2):106-9.

18.

Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.

Saengboonmee C, Seubwai W, Cha'on U, Sawanyawisuth K, Wongkham S, Wongkham C.

Anticancer Res. 2017 Jan;37(1):115-123.

PMID:
28011481
19.

An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma.

Marzioni M, Torrice A, Saccomanno S, Rychlicki C, Agostinelli L, Pierantonelli I, Rhönnstad P, Trozzi L, Apelqvist T, Gentile R, Candelaresi C, Fava G, Semeraro R, Benedetti A, Gaudio E, Franchitto A, Onori P, De Minicis S, Carpino G, Kallin E, Alvaro D, Nilsson S.

Dig Liver Dis. 2012 Feb;44(2):134-42. doi: 10.1016/j.dld.2011.06.014. Epub 2011 Jul 22.

PMID:
21782536
20.

Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma.

Hou YJ, Dong LW, Tan YX, Yang GZ, Pan YF, Li Z, Tang L, Wang M, Wang Q, Wang HY.

Lab Invest. 2011 Aug;91(8):1146-57. doi: 10.1038/labinvest.2011.97. Epub 2011 Jun 6.

Supplemental Content

Support Center